James A. Eastham

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial”.

Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial

European Urology Oncology(2021)10.1016/j.euo.2021.03.006

N/A

6.3DataRank · unranked

170 citations

Daniel D. Sjoberg, Nicole Benfante, Vincent P. Laudone, Behfar Ehdaie, James A. Eastham +3 more

Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended Dissection

European Urology(2024)10.1016/j.eururo.2024.10.006

N/A

1.5DataRank · unranked

57 citations

Emily Vertosick, Daniel D. Sjoberg, Nicole Liso, Sunny Nalavenkata, Bárbara Vieira Lima Aguiar Melão +7 more

Genetic factors associated with prostate cancer conversion from active surveillance to treatment

Human Genetics and Genomics Advances(2021)10.1016/j.xhgg.2021.100070

N/A

0DataRank · unranked

23 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms

European Urology Open Science(2021)10.1016/j.euros.2021.06.002

N/A

0DataRank · unranked

7 citations

Emily Vertosick, Spyridon P. Basourakos, James A. Eastham, Behfar Ehdaie, Peter T. Scardino +3 more

Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.01.011

N/A

0DataRank · unranked

4 citations

Amy L. Tin, Arjun Sivaraman, Toshikazu Takeda, Taehyoung Lee, Jonathan Fainberg +11 more

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

medRxiv(2021)10.1101/2021.08.30.21262305

N/A

0DataRank · unranked

14 citations

Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki +92 more

Patient-reported financial toxicity following management of localized prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17053

N/A

0DataRank · unranked

1 citations

Amy L. Tin, Andrew J. Vickers, James A. Eastham, Michael J. Zeléfsky, Behfar Ehdaie +2 more

Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5022

N/A

0DataRank · unranked

1 citations

Kelsey Breen, Yelena Kemel, Andrew T. Lenis, Peter A. Reisz, Nicole Benfante +15 more

Relationship Between Age, Comorbidity, and the Prevalence of Erectile Dysfunction

European Urology Focus(2022)10.1016/j.euf.2022.08.006

N/A

0DataRank · unranked

69 citations

Daniel D. Sjoberg, Amy L. Tin, Nicole Benfante, Alberto Briganti, Francesco Montorsi +4 more

Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past?

European Urology Focus(2022)10.1016/j.euf.2022.10.002

N/A

0DataRank · unranked

41 citations

Amy L. Tin, Alberto Martini, Emily Vertosick, Shaun P Porwal, Armando Stabile +6 more

Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer

Frontiers in Oncology(2022)10.3389/fonc.2022.929444

N/A

0DataRank · unranked

16 citations

Arthur Yim, Nathan Papa, Shankar Siva, Joseph Ischia, Karim Touijer +4 more

Genitourinary tumors

Journal of Surgical Oncology(2022)10.1002/jso.27031

N/A

0DataRank · unranked

5 citations

Pramod C. Sogani, James A. Eastham, Harry W. Herr

Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance

European Urology Focus(2022)10.1016/j.euf.2022.12.008

N/A

0DataRank · unranked

9 citations

Ghalib Jibara, Amy L. Tin, Samuel Haywood, Daniel D. Sjoberg, Nicole Benfante +9 more

Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence

Urologic Oncology Seminars and Original Investigations(2022)10.1016/j.urolonc.2022.10.021

N/A

0DataRank · unranked

4 citations

Souhil Lebdai, Amy L. Tin, Daniel D. Sjoberg, Nicole Benfante, Benjamin Beech +9 more

A randomized trial on pelvic lymph node dissection versus no lymph node dissection at radical prostatectomy: Report of a trial in progress.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps5116

N/A

0DataRank · unranked

5 citations

Erin Carroll, Jessica Carruthers, Timothy F. Donahue, James A. Eastham, Behfar Ehdaie +9 more

The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy

Cancer(2023)10.1002/cncr.34981

N/A

0DataRank · unranked

18 citations

Amy L. Tin, Jonathan Fainberg, Samson W. Fine, Ghalib Jibara, Karim Touijer +6 more

Active surveillance should be considered for select men with Grade Group 2 prostate cancer

BMC Urology(2023)10.1186/s12894-023-01314-6

N/A

0DataRank · unranked

14 citations

Oskar Bergengren, James A. Eastham, Sigrid Carlsson, Kelly R. Pekala

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad184

N/A

0DataRank · unranked

9 citations

Xiaofei Wang, Evan W. Warner, Andrea Sboner, Matti Annala, Michael Sigouros +13 more

The Highest Grade Group Does Not Drive the Risk of Recurrence when Systematic and Multiparametric Magnetic Resonance Imaging (MRI)-targeted Biopsies are Discordant: Preliminary Findings Using Radical Prostatectomy Pathology as a Surrogate for MRI-targeted Biopsy Grade

European Urology Focus(2023)10.1016/j.euf.2023.07.011

N/A

0DataRank · unranked

4 citations

Francesco Pellegrino, Amy L. Tin, Benjamin Beech, Giorgio Gandaglia, Armando Stabile +5 more

Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy

World Journal of Urology(2023)10.1007/s00345-023-04420-0

N/A

0DataRank · unranked

2 citations

Daniel D. Sjoberg, Amy L. Tin, Nicole Benfante, Alberto Briganti, Francesco Montorsi +6 more

The effect of the da Vinci® Vessel Sealer on robot-assisted laparoscopic prostatectomy complications

Journal of Robotic Surgery(2023)10.1007/s11701-023-01595-x

N/A

0DataRank · unranked

1 citations

Amy L. Tin, Daniel D. Sjoberg, Nicole Benfante, Ryan Weber, Shaun Porwal +6 more

Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102204

N/A

0DataRank · unranked

8 citations

Melissa Assel, Sunny Nalavenkata, Sari Khaleel, Nicole Benfante, Sigrid Carlsson +9 more

Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?

The Journal of Urology(2024)10.1097/ju.0000000000003823

N/A

0DataRank · unranked

5 citations

Emily Vertosick, Lawrence C. Jenkins, John E. Cooper, Nicole Benfante, Daniel D. Sjoberg +7 more

Implementation and Validation of an Automated, Longitudinal Robotic Surgical Evaluation and Feedback Program at a High-volume Center and Impact on Training

European Urology Open Science(2024)10.1016/j.euros.2024.02.014

N/A

0DataRank · unranked

5 citations

Emily Vertosick, Daniel D. Sjoberg, Eugene K. Cha, Jonathan Coleman, Timothy F. Donahue +7 more

Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic Efficacy

Urology Practice(2024)10.1097/upj.0000000000000666

N/A

0DataRank · unranked

1 citations

Taehyoung Lee, Emily Vertosick, Arjun Sivaraman, Gregory T. Chesnut, Samson W. Fine +4 more

Prostate-specific antigen levels at age 60 years and lifetime risk of lethal prostate cancer

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf271

N/A

0DataRank · unranked

3 citations

Andrew J. Vickers, Anders Dahlin, David Ulmert, Sigrid Carlsson, James A. Eastham +3 more

Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging–targeted prostate biopsy grade groups are discordant

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf275

N/A

0DataRank · unranked

1 citations

Targeted Biopsies Prostate Cancer Collaborative Group, Francesco Montorsi, Alberto Briganti, Armando Stabile, Amy L. Tin +57 more

Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy

Nature Reviews Urology(2021)10.1038/s41585-021-00445-5

N/A

0DataRank · unranked

92 citations

Sigrid Carlsson, G. C. Gass, Petra L. Graham, Jaspreet S. Sandhu, Oğuz Akın +4 more